Literature DB >> 16846232

Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions.

Todd T Talley1, Samar Yalda, Kwok-Yiu Ho, Yitzhak Tor, Ferene S Soti, William R Kem, Palmer Taylor.   

Abstract

The discovery of the acetylcholine binding proteins (AChBPs) has provided critical soluble surrogates for examining structure and ligand interactions with nicotinic receptors and related pentameric ligand-gated ion channels. The multiple marine and freshwater sources of AChBP constitute a protein family with substantial sequence divergence and selectivity in ligand recognition for analyzing structure-activity relationships. The purification of AChBP in substantial quantities in the absence of a detergent enables one to conduct spectroscopic studies of the ligand-AChBP complexes. To this end, we have examined the interaction of a congeneric series of benzylidene-ring substituted anabaseines with AChBPs from Lymnaea, Aplysia, and Bulinus species and correlated their binding energetics with spectroscopic changes associated with ligand binding. The anabaseines display agonist activity on the alpha7 nicotinic receptor, a homomeric receptor with sequences similar to those of the AChBPs. Substituted anabaseines show absorbance and fluorescence properties sensitive to the protonation state, relative permittivity (dielectric constant), and the polarizability of the surrounding solvent or the proximal residues in the binding site. Absorbance difference spectra reveal that a single protonation state of the ligand binds to AChBP and that the bound ligand experiences a solvent environment with a high degree of polarizability. Changes in the fluorescence quantum yield of the bound ligand reflect the rigidification of the ring system of the bound ligand. Hence, the spectral properties of the bound ligand allow a description of the electronic character of the bound state of the ligand within its aromatic binding pocket and provide information complementary to that of crystal structures in defining the determinants of interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846232      PMCID: PMC3222595          DOI: 10.1021/bi060534y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers.

Authors:  Harumi Kitagawa; Toshiharu Takenouchi; Ryotaro Azuma; Keith A Wesnes; William G Kramer; Donald E Clody; Angela L Burnett
Journal:  Neuropsychopharmacology       Date:  2002-07-11       Impact factor: 7.853

2.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Authors:  Ann Olincy; Josette G Harris; Lynn L Johnson; Vicki Pender; Susan Kongs; Diana Allensworth; Jamey Ellis; Gary O Zerbe; Sherry Leonard; Karen E Stevens; James O Stevens; Laura Martin; Lawrence E Adler; Ferenc Soti; William R Kem; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2006-06

4.  Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.

Authors:  T K Machu; M E Hamilton; T F Frye; C L Shanklin; M C Harris; H Sun; T E Tenner; F S Soti; W R Kem
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

5.  Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

Authors:  K E Stevens; W R Kem; V M Mahnir; R Freedman
Journal:  Psychopharmacology (Berl)       Date:  1998-04       Impact factor: 4.530

6.  Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.

Authors:  Yves Bourne; Todd T Talley; Scott B Hansen; Palmer Taylor; Pascale Marchot
Journal:  EMBO J       Date:  2005-03-24       Impact factor: 11.598

7.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.

Authors:  Scott B Hansen; Gerlind Sulzenbacher; Tom Huxford; Pascale Marchot; Palmer Taylor; Yves Bourne
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

8.  Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors.

Authors:  Patrick H N Celie; Remco V Klaassen; Sarah E van Rossum-Fikkert; René van Elk; Pim van Nierop; August B Smit; Titia K Sixma
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

9.  Tryptophan fluorescence reveals conformational changes in the acetylcholine binding protein.

Authors:  Scott B Hansen; Zoran Radic'; Todd T Talley; Brian E Molles; Tom Deerinck; Igor Tsigelny; Palmer Taylor
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

10.  DMXB, an alpha7 nicotinic agonist, normalizes auditory gating in isolation-reared rats.

Authors:  Heidi C O'Neill; Kate Rieger; William R Kem; Karen E Stevens
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

View more
  26 in total

1.  Defining the determinants of nicotine selectivity.

Authors:  Palmer Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Virtual screening against acetylcholine binding protein.

Authors:  Maleeruk Utsintong; Piyanuch Rojsanga; Kwok-Yiu Ho; Todd T Talley; Arthur J Olson; Kinzo Matsumoto; Opa Vajragupta
Journal:  J Biomol Screen       Date:  2011-09-28

3.  Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.

Authors:  Akos Nemecz; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 4.  Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes.

Authors:  Palmer Taylor; Todd T Talley; Zoran Radic'; Scott B Hansen; Ryan E Hibbs; Jian Shi
Journal:  Biochem Pharmacol       Date:  2007-08-03       Impact factor: 5.858

5.  Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.

Authors:  David C Kombo; Anatoly Mazurov; Kartik Tallapragada; Philip S Hammond; Joseph Chewning; Terry A Hauser; Montserrat Vasquez-Valdivieso; Daniel Yohannes; Todd T Talley; Palmer Taylor; William S Caldwell
Journal:  Eur J Med Chem       Date:  2011-09-29       Impact factor: 6.514

6.  Generation of candidate ligands for nicotinic acetylcholine receptors via in situ click chemistry with a soluble acetylcholine binding protein template.

Authors:  Neil P Grimster; Bernhard Stump; Joseph R Fotsing; Timo Weide; Todd T Talley; John G Yamauchi; Ákos Nemecz; Choel Kim; Kwok-Yiu Ho; K Barry Sharpless; Palmer Taylor; Valery V Fokin
Journal:  J Am Chem Soc       Date:  2012-04-06       Impact factor: 15.419

7.  Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding.

Authors:  Xiaoqin Huang; Fang Zheng; Clare Stokes; Roger L Papke; Chang-Guo Zhan
Journal:  J Med Chem       Date:  2008-10-01       Impact factor: 7.446

8.  Mapping the elusive neonicotinoid binding site.

Authors:  Motohiro Tomizawa; Todd T Talley; David Maltby; Kathleen A Durkin; Katalin F Medzihradszky; Alma L Burlingame; Palmer Taylor; John E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

9.  Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.

Authors:  Ryan E Hibbs; Gerlind Sulzenbacher; Jianxin Shi; Todd T Talley; Sandrine Conrod; William R Kem; Palmer Taylor; Pascale Marchot; Yves Bourne
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

10.  Nicotine binding to brain receptors requires a strong cation-pi interaction.

Authors:  Xinan Xiu; Nyssa L Puskar; Jai A P Shanata; Henry A Lester; Dennis A Dougherty
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.